| 1 |
2023 |
Glòria Salort, María Álvaro-Bartolomé, Jesús A. García-Sevilla. Cannabinoid CB2 receptor ligands disrupt the sequential regulation of p-MEK1/2 to p-ERK1/2 in mouse brain cortex, Exploration of Neuroprotective Therapy. 2023; 3: 258.
https://doi.org/10.37349/ent.2023.00050 |
| 2 |
2024 |
Fabien Chauveau, Alexandra Winkeler, Sylvie Chalon, Hervé Boutin, Guillaume Becker. PET imaging of neuroinflammation: any credible alternatives to TSPO yet?, Molecular Psychiatry. 2024;
https://doi.org/10.1038/s41380-024-02656-9 |
| 3 |
2022 |
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, Emmanuel S. Onaivi. Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders, Frontiers in Psychiatry. 2022; 13: 828895.
https://doi.org/10.3389/fpsyt.2022.828895 |
